Rafferty Asset Management Portfolio holdings
AUM
$30.3B
1-Year Return
18.89%
This Quarter Return
+10.63%
1 Year Return
+18.89%
3 Year Return
+101.02%
5 Year Return
+164.75%
10 Year Return
+314.44%
AUM
$26.8B
AUM Growth
+$3.09B
(+13%)
Cap. Flow
+$1.27B
Cap. Flow
% of AUM
4.74%
Top 10 Holdings %
Top 10 Hldgs %
40.07%
Holding
1,108
New
38
Increased
406
Reduced
634
Closed
28
Top Buys
| 1 |
Intel
INTC
|
+$208M |
| 2 |
Microchip Technology
MCHP
|
+$134M |
| 3 |
Qualcomm
QCOM
|
+$122M |
| 4 |
Analog Devices
ADI
|
+$122M |
| 5 |
Micron Technology
MU
|
+$113M |
Top Sells
| 1 |
iShares Russell 2000 ETF
IWM
|
+$326M |
| 2 |
NVIDIA
NVDA
|
+$116M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$78.6M |
| 4 |
iShares China Large-Cap ETF
FXI
|
+$72.7M |
| 5 |
KraneShares CSI China Internet ETF
KWEB
|
+$36.4M |
Sector Composition
| 1 | Technology | 47.46% |
| 2 | Financials | 9.33% |
| 3 | Healthcare | 6.2% |
| 4 | Consumer Discretionary | 3.62% |
| 5 | Energy | 2.45% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
MRO
251
DELISTED
Marathon Oil Corporation
MRO
| $10.6M | 0.04% |
373,666
-71,932
| -16% | -$2.04M |
|
252
Exact Sciences
EXAS
$10.3B
| $10.5M | 0.04% |
152,740
+14,021
| +10% | +$968K |
|
253
TransDigm Group
TDG
$73.1B
| $10.5M | 0.04% |
8,549
-1,574
| -16% | -$1.94M |
|
254
Cadence Bank
CADE
$6.97B
| $10.5M | 0.04% |
362,723
+30,791
| +9% | +$893K |
|
255
Oneok
OKE
$45.6B
| $10.5M | 0.04% |
130,701
-21,277
| -14% | -$1.71M |
|
256
Viking Therapeutics
VKTX
$2.84B
| $10.5M | 0.04% |
127,756
-285,522
| -69% | -$23.4M |
|
257
Eaton
ETN
$142B
| $10.4M | 0.04% |
33,213
-277
| -0.8% | -$86.6K |
|
258
Northrop Grumman
NOC
$82.8B
| $10.4M | 0.04% |
21,677
-1,201
| -5% | -$575K |
|
259
CVS Health
CVS
$92.5B
| $10.4M | 0.04% |
129,884
-854
| -0.7% | -$68.1K |
|
260
Boston Scientific
BSX
$155B
| $10.4M | 0.04% |
151,189
+2,133
| +1% | +$146K |
|
261
Crinetics Pharmaceuticals
CRNX
$3.36B
| $10.2M | 0.04% |
216,849
-27,440
| -11% | -$1.28M |
|
262
Fair Isaac
FICO
$37B
| $10.1M | 0.04% |
8,090
-65
| -0.8% | -$81.2K |
|
263
General Dynamics
GD
$86.9B
| $10.1M | 0.04% |
35,642
-4,306
| -11% | -$1.22M |
|
264
T Rowe Price
TROW
$23.6B
| $10.1M | 0.04% |
82,495
-1,454
| -2% | -$177K |
|
265
TJX Companies
TJX
$155B
| $9.96M | 0.04% |
98,158
-4,946
| -5% | -$502K |
|
266
Willis Towers Watson
WTW
$32.2B
| $9.92M | 0.04% |
36,089
-520
| -1% | -$143K |
|
267
Builders FirstSource
BLDR
$15.6B
| $9.85M | 0.04% |
47,225
-1,094
| -2% | -$228K |
|
268
Columbia Banking Systems
COLB
$7.93B
| $9.81M | 0.04% |
506,804
+160,496
| +46% | +$3.11M |
|
269
Exelixis
EXEL
$10.3B
| $9.8M | 0.04% |
412,897
+4,818
| +1% | +$114K |
|
270
Incyte
INCY
$16.8B
| $9.8M | 0.04% |
171,985
-11,079
| -6% | -$631K |
|
271
Cullen/Frost Bankers
CFR
$8.18B
| $9.79M | 0.04% |
86,956
-31,288
| -26% | -$3.52M |
|
272
BridgeBio Pharma
BBIO
$10.1B
| $9.78M | 0.04% |
316,442
+40,369
| +15% | +$1.25M |
|
273
Cytokinetics
CYTK
$6.12B
| $9.78M | 0.04% |
139,477
-123,798
| -47% | -$8.68M |
|
274
Dyne Therapeutics
DYN
$1.87B
| $9.78M | 0.04% |
344,391
+180,350
| +110% | +$5.12M |
|
275
Roivant Sciences
ROIV
$9.31B
| $9.61M | 0.04% |
912,193
-60,941
| -6% | -$642K |
|